BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3464850)

  • 1. [Usefulness of the determination of CA 19-9 in the follow-up of patients with gastroenteric neoplasms in comparison to CEA].
    Pecchio F; Piantino P; Oliaro A; Rapellino M; Ricci E; Aimo G; Obert R
    Minerva Med; 1986 Nov; 77(42-43):1973-81. PubMed ID: 3464850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic value of a new serum marker of human digestive cancer: the carbohydrate antigen 19.9; comparison with the carcinoembryonic antigen].
    Olsson NO; Crimet-Montange D; Martin F
    Gastroenterol Clin Biol; 1985 Mar; 9(3):206-11. PubMed ID: 3859449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
    Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
    Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CA 12-5 in cancer of the digestive tract. A comparison with CA 19-9 and CEA in cancer of the pancreas and colon].
    Klapdor R; Klapdor U; Bahlo M; Dallek M; Kremer B; van Ackeren H; Schreiber HW; Greten H
    Dtsch Med Wochenschr; 1984 Dec; 109(51-52):1949-54. PubMed ID: 6595110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estimates of circulating breast cancer-associated antigen CA 15-3 as a monitoring marker in patients with breast cancer].
    Yoshimoto M; Akiyama F; Watanabe S; Kasumi F; Fukami A; Nakajima T; Nishi M; Kajitani T; Takahashi S
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2310-5. PubMed ID: 3475042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of the efficacy of the combined determination of serum markers CEA, CA 19.9, CA 72.4 as indexes of gastro-intestinal tract neoplasms].
    Marchei P; Cifaldi L; De Benedetto A; Santini D; Manna A; Trasatti L; Marchei GG; Reale MG
    G Ital Oncol; 1990; 10(4):121-4. PubMed ID: 2093080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
    Tappero G; Piantino P; Cerchier A; Pecchio F
    Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of the circulating tumor-associated antigen CA 19-9 in cancers of the digestive tract].
    Staab HJ; Hornung A; Anderer FA; Kieninger G
    Dtsch Med Wochenschr; 1984 Jul; 109(30):1141-7. PubMed ID: 6204834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma.
    Picardo AL; Diez M; Torres A; Maestro M; Ortega D; Hernando F; Gómez A; Garcia-Asenjo J; Balibrea JL
    Cancer; 1996 Mar; 77(6):1066-72. PubMed ID: 8635125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of 3 markers in ovarian cancer: CA 125, CA 19,9 and CEA].
    Vigné E; Krebs B; Khater R; Mira R; Boublil JL; Jourlait A; Frenay M; Namer M
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(5):609-13. PubMed ID: 3463621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system.
    Sakamoto K; Haga Y; Yoshimura R; Egami H; Yokoyama Y; Akagi M
    Gut; 1987 Mar; 28(3):323-9. PubMed ID: 3471687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CA 19-9 in neoplasms. Comparison with CEA].
    Nakad A; Jonard P; Geubel A; Warzee P; Coppens JP; Dehennin JP; Dive C
    Acta Gastroenterol Belg; 1987; 50(1):36-44. PubMed ID: 3480669
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antigens CA-50 and CA-242 in digestive tract and thyroid neoplasms].
    Pomorski L; Pasieka Z; Kołomecki K; Czyz W; Kołodziejczyk M; Wróbel B
    Wiad Lek; 1997; 50 Suppl 1 Pt 1():18-20. PubMed ID: 9446350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
    Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
    Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
    Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
    J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoclonal antibodies. Their usefulness in the diagnosis of malignant tumors of the digestive system].
    Campos Campos F; Romero Navarro MA; Gutiérrez Samperio C; Esquivel P; Gaviño Chapa JF
    Rev Gastroenterol Mex; 1989; 54(4):193-8. PubMed ID: 2616981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CA 15-3 in the diagnosis and monitoring of carcinoma of the breast and its correlations with CEA].
    Festa V; Alabiso O; Piantino P; Lisa F; Zanini M; Garrone C; Simone P; Morino M
    Minerva Chir; 1989 Mar; 44(6):1015-20. PubMed ID: 2733831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of the determination of CEA and Ca 19-9 in the diagnosis and staging of bronchial carcinoma].
    Rapellino M; Pecchio F; Baldi S; Obert R; Bevilacqua Rapellino A; Libertucci D; Coni F; Oliaro A
    Minerva Med; 1987 Mar; 78(6):373-5. PubMed ID: 3470632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CA-50: evaluation of a new tumor marker in the diagnosis of neoplastic pathologies of the gastrointestinal tract].
    Pecchio F; Ricci E; Rapellino M; Oliaro A; Adamo MR; Marzola G; Piantino P
    Minerva Med; 1987 Feb; 78(3):141-4. PubMed ID: 3469541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
    Schatz C; von Lieven H; Mulders M; Rowold J; Stracke H; Müller H; Grebe SF; Schatz H
    Wien Klin Wochenschr; 1985 Dec; 97(23):873-9. PubMed ID: 3878042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.